Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The role of the opioid system in controlling pain, reward and addiction is well established, but its role in regulating other emotional responses is poorly documented in pharmacology. The mu-, delta- and kappa- opioid receptors (encoded by Oprm, Oprd1 and Oprk1, respectively) mediate the biological activity of opioids. We have generated Oprd1-deficient mice and compared the behavioural responses of mice lacking Oprd1, Oprm (ref. 6) and Oprk1 (ref. 7) in several models of anxiety and depression. Our data show no detectable phenotype in Oprk1-/- mutants, suggesting that kappa-receptors do not have a role in this aspect of opioid function; opposing phenotypes in Oprm-/- and Oprd1-/- mutants which contrasts with the classical notion of similar activities of mu- and delta-receptors; and consistent anxiogenic- and depressive-like responses in Oprd1-/- mice, indicating that delta-receptor activity contributes to improvement of mood states. We conclude that the Oprd1-encoded receptor, which has been proposed to be a promising target for the clinical management of pain, should also be considered in the treatment of drug addiction and other mood-related disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, agonism of the delta-opioid receptor, the primary receptor target of enkephalin, promotes antidepressant outcomes (80), while delta receptor knockout promotes depressive-like behavior (81).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [81]
Citations
Cites
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 3,320
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722
Self-citationOpioid-receptor mRNA expression in the rat CNS: anatomical and functional implications
Mansour, A., Fox, C. A., Akil, H., & Watson, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93946-u · Cited by 1,292
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072
Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C., & Hirth, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12048 · Cited by 1,010
Self-citationTimpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M. H. M., Stalla, G. K., Blanquet, V., Steckler, T., Holsboer, F., & Wurst, W. (1998) · Nature Genetics · doi:10.1038/520 · Cited by 919
Lufkin, T., Dierich, A., LeMeur, M., Mark, M., & Chambon, P. (1991) · Cell · doi:10.1016/0092-8674(91)90034-v · Cited by 697
Self-citationDecreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues
Crestani, F., Lorez, M., Baer, K., Essrich, C., Benke, D., Laurent, J. P., Belzung, C., Fritschy, J.-M., Lüscher, B., & Mohler, H. (1999) · Nature Neuroscience · doi:10.1038/12207 · Cited by 550
Cited by
Items 201–300 of 692
Chefer, V. I., Kieffer, B. L., & Shippenberg, T. S. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02912.x · Cited by 58
Self-citationκ-Opioid Receptors in the Central Amygdala Regulate Ethanol Actions at Presynaptic GABAergic Sites
Kang-Park, M.-H., Kieffer, B. L., Roberts, A. J., Siggins, G. R., & Moore, S. D. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.202903 · Cited by 59
Self-citationClarke, S., Zimmer, A., Zimmer, A., Hill, R. G., & Kitchen, I. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.07.011 · Cited by 65
Balerio, G. N., Aso, E., & Maldonado, R. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2238-y · Cited by 60
Self-citationPreclinical Pharmacology of AZD2327: A Highly Selective Agonist of the δ-Opioid Receptor
Hudzik, T. J., Maciag, C. M., Smith, M. A., CACCESE, R. G., Pietras, M. R., Bui, K., Coupal, M., Adam, L., Payza, K., Griffin, A. M., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.179432 · Cited by 55
Reduced emotional and corticosterone responses to stress in μ-opioid receptor knockout mice
Ide, S., Sora, I., Ikeda, K., Minami, M., Uhl, G. R., & Ishihara, K. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.005 · Cited by 52
David, V., Matifas, A., Gavello-Baudy, S., Decorte, L., Kieffer, B. L., & Cazala, P. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301529 · Cited by 57
Self-citationThe opioid system and the social brain: implications for depression and suicide
Lutz, P., Courtet, P., & Calati, R. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24269 · Cited by 53
“The opioid system regulates many aspects of physiology, including reward (Lutz and Kieffer 2013a; Russo and Nestler 2013), mood states (Filliol et al. 2000; Lutz and Kieffer 2013b), and stress responses (see (Bodnar 2011) for an extensive overview).”
BackgroundDifferential noxious and motor tolerance of chronic delta opioid receptor agonists in rodents
Beaudry, H., Proteau‐Gagné, A., Li, S., Dory, Y. L., Chavkin, C., & Gendron, L. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.053 · Cited by 52
The antidepressant-like effect of human opiorphin via opioid-dependent pathways in mice
Yang, Q.-Z., Lu, S., Tian, X., Yang, A., Ge, W.-W., & Chen, Q. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.12.002 · Cited by 52
Opioid Receptor Interacting Proteins and the Control of Opioid Signaling
Lamberts, J. T., & Traynor, J. R. (2014) · Current Pharmaceutical Design · doi:10.2174/138161281942140105160625 · Cited by 52
Dorsal hippocampal opioidergic system modulates anxiety‐like behaviors in adult male Wistar rats
Solati, J., Zarrindast, M., & Salari, A. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02143.x · Cited by 53
Involvement of opioid system in behavioral despair induced by social isolation stress in mice
Haj‐Mirzaian, A., Nikbakhsh, R., Ramezanzadeh, K., Rezaee, M., Amini-Khoei, H., Haj‐Mirzaian, A., Ghesmati, M., Afshari, K., Haddadi, N., & Dehpour, A. R. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.144 · Cited by 53
Antidepressant-Like Effect of Endomorphin-1 and Endomorphin-2 in Mice
Fichna, J., Janecka, A. E., Piestrzeniewicz, M. K., Costentin, J., & do-Rego, J.-C. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301149 · Cited by 55
Ghozland, S. G., CHU, K., Kieffer, B. L., & Roberts, A. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.006 · Cited by 51
Self-citationMittal, N., Roberts, K., Pal, K., Bentolila, L. A., Fultz, E. K., Minasyan, A., Cahill, C. M., Pradhan, A. A. A., Conner, D. A., DeFea, K., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.015 · Cited by 51
Martín‐García, E., Mannara, F., Cuesta, J., Sabater, L., Dalmau, J. O., Maldonado, R. J., & Graus, F. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.05.003 · Cited by 51
Self-citationRecent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics
Remesic, M., Hruby, V. J., Porreca, F., & Lee, Y. S. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00090 · Cited by 52
Faget, L. C., Erbs, E., Merrer, J. L., Scherrer, G., Matifas, A., Benturquia, N., Noble, F., Décossas, M., Koch, M., Kessler, P., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0185-12.2012 · Cited by 54
Self-citationThe opioid placebo analgesia is mediated exclusively through µ-opioid receptor in rat
Zhang, R.-R., Zhang, W.-C., Wang, J.-Y., & Guo, J.-Y. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000673 · Cited by 47
The Opioid System in Temporal Lobe Epilepsy: Functional Role and Therapeutic Potential
Burtscher, J., & Schwarzer, C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00245 · Cited by 52
Reduced nucleus accumbens enkephalins underlie vulnerability to social defeat stress
Nam, H., Chandra, R., Francis, T. C., Dias, C., Cheer, J. F., & Lobo, M. K. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0422-8 · Cited by 51
Folic acid ameliorates depression-like behaviour in a rat model of chronic unpredictable mild stress
Zhou, Y., Cong, Y., & Liu, H. (2020) · BMC Neuroscience · doi:10.1186/s12868-020-0551-3 · Cited by 51
Wöhr, M., Moles, A., Schwarting, R. K. W., & D'Amato, F. R. (2011) · Social Neuroscience · doi:10.1080/17470911003765560 · Cited by 45
Changes in Emotional Behavior of Mice in the Hole-Board Test After Olfactory Bulbectomy
Saitoh, A., Hirose, N., Yamada, M., Yamada, M., Nozaki, C., Oka, T., & Kamei, J. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0060837 · Cited by 48
Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats
Liu, X., Palmatier, M. I., Caggiula, A. R., Sved, A. F., Donny, E. C., Gharib, M. A., & Booth, S. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1335-0 · Cited by 51
Molecular foundation of anxiety disorders
Lesch, K. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170048 · Cited by 56
Gavériaux‐Ruff, C., Filliol, D., Simonin, F., Matthes, H. W. D., & Kieffer, B. L. (2001) · PubMed · Cited by 48
Self-citationStanczyk, M. A., Livingston, K. E., Chang, L. C., Weinberg, Z. Y., Puthenveedu, M. A., & Traynor, J. R. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14602 · Cited by 48
Nielsen, C. K., Simms, J. A., Pierson, H. B., Li, R., Saini, S. K., Ananthan, S., & Bartlett, S. E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.07.018 · Cited by 50
Direct Agonist Activity of Tricyclic Antidepressants at Distinct Opioid Receptor Subtypes
Onali, P., Dedoni, S., & Olianas, M. C. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.159939 · Cited by 50
The antiallodynic action of pregabalin in neuropathic pain is independent from the opioid system
Kremer, M., Yalçın, İ., Nexon, L., Wurtz, X., Ceredig, R. A., Daniel, D., Hawkes, R. A., Salvat, É., & Barrot, M. (2016) · Molecular Pain · doi:10.1177/1744806916633477 · Cited by 48
Watanabe, H., Fitting, S., Hussain, M. Z., Kononenko, O., Iatsyshyna, A. P., Yoshitake, T., Kehr, J., Alkass, K., Druid, H., Wadensten, H., et al. (2013) · Cerebral Cortex · doi:10.1093/cercor/bht204 · Cited by 47
Migraine Treatment: Towards New Pharmacological Targets
Silvestro, M., Iannone, L. F., Orologio, I., Tessitore, A., Tedeschi, G., Geppetti, P., & Russo, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512268 · Cited by 46
A Novel Anxiogenic Role for the Delta Opioid Receptor Expressed in GABAergic Forebrain Neurons
Chung, P. C. S., Keyworth, H. L., Martín‐García, E., Charbogne, P., Darcq, E., Bailey, A., Filliol, D., Matifas, A., Scherrer, G., Ouagazzal, A., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.033 · Cited by 50
Self-citationThe delta opioid receptor tool box
Vicente‐Sánchez, A., Segura, L., & Pradhan, A. A. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.028 · Cited by 49
Saul, M. C., Majdak, P., Perez, S., Reilly, M., Garland, T., & Rhodes, J. S. (2016) · Genes Brain & Behavior · doi:10.1111/gbb.12347 · Cited by 51
Popik, P., Kamysz, E., Kreczko–Kurzawa, J., & Wróbel, M. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.04.045 · Cited by 45
Saitoh, A., Sugiyama, A., Yamada, M., Inagaki, M., Oka, J., Nagase, H., & Yamada, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.025 · Cited by 45
Nozaki, C., Nagase, H., Nemoto, T., Matifas, A., Kieffer, B. L., & Gavériaux‐Ruff, C. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12852 · Cited by 44
Self-citationBerrendero, F., Mendizábal, V. E., Murtra, P., Kieffer, B. L., & Maldonado, R. J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02951.x · Cited by 47
Self-citationEmotional perception modulated by an opioid and a cholecystokinin agonist
Gospic, K. A. M., Gunnarsson, T., Fransson, P., Ingvar, M., Lindefors, N., & Petrović, P. (2007) · Psychopharmacology · doi:10.1007/s00213-007-1032-4 · Cited by 46
Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence
Célèrier, E., Ahdepil, T., Wikander, H., Berrendero, F., Nyberg, F., & Maldonado, R. J. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.017 · Cited by 44
Self-citationJohnson, T. A., Milan‐Lobo, L., Che, T., Ferwerda, M., Lambu, E., McIntosh, N. L., Li, F., He, L., Lorig‐Roach, N., Crews, P., et al. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00167 · Cited by 50
Mechanisms for the Regulation of State Changes in the Central Nervous System: An Introduction
Pfaff, D. W., Kieffer, B. L., & Swanson, L. W. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1417.031 · Cited by 43
Self-citationChieng, B. C. H., & Christie, M. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.034 · Cited by 43
Lee, Y., Choi, D.-Y., Jung, Y., Yun, Y., Lee, B., Han, S., & Hong, J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.10.030 · Cited by 40
Yoo, J., Lee, S., Loh, H. H., Ho, I. K., & Jang, C. (2004) · Synapse · doi:10.1002/syn.20067 · Cited by 46
Influence of δ-Opioid Receptors in the Behavioral Effects of Nicotine
Berrendero, F., Plaza‐Zabala, A., Galeote, L., Flores, Á., Bura, S. A., Kieffer, B. L., & Maldonado, R. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.88 · Cited by 48
Self-citationNielsen, C. K., Simms, J. A., Li, R., Mill, D., Yi, H. Y., Feduccia, A. A., Santos, N., & Bartlett, S. E. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5345-11.2012 · Cited by 45
Bauer, I. E., Soares, J. C., & Nielsen, D. A. (2014) · American Journal on Addictions · doi:10.1111/ajad.12172 · Cited by 42
The role of delta opioid receptors in the anxiolytic actions of benzodiazepines
Primeaux, S. D., WILSON, S., MCDONALD, A., Mascagni, F., & Wilson, M. A. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.09.025 · Cited by 42
Dickenson, A. H., & Kieffer, B. L. (2006) · Elsevier eBooks · doi:10.1016/b0-443-07287-6/50032-1 · Cited by 47
Self-citationNakamoto, K., & Tokuyama, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411713 · Cited by 42
Naidu, P. S., Lichtman, A. H., Archer, C. C., May, E. L., Harris, L. S., & Aceto, M. D. G. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.03.031 · Cited by 41
Neuropeptides in Anxiety Modulation
Landgraf, R. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-28082-0_12 · Cited by 48
Saitoh, A., Yamada, M., Yamada, M., Takahashi, K., Yamaguchi, K., Murasawa, H., Nakatani, A., Tatsumi, Y., Hirose, N., & Kamei, J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.07.095 · Cited by 41
Pinhasov, A., Crooke, J. J., Rosenthal, D., Brenneman, D. E., & Malatyńska, E. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200512000-00009 · Cited by 41
Aguila, B., Coulbault, L., Boulouard, M., Lιveillι, F., Davis, A., Tσth, G., Borsodi, A. D., Balboni, G., Salvadori, S., Jauzac, P., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707497 · Cited by 41
Berrocoso, E., Rojas-Corrales, M. O., & Micó, J. A. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.03.041 · Cited by 41
Delta-opioid receptors as targets for migraine therapy
Charles, A. C., & Pradhan, A. A. A. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000311 · Cited by 41
Congenic C57BL/6 µ opiate receptor (MOR) knockout mice: baseline and opiate effects
Hall, F. S., Li, X. ‐., Goeb, M., Roff, S. R., Hoggatt, H., Sora, I., & Uhl, G. R. (2003) · Genes Brain & Behavior · doi:10.1034/j.1601-183x.2003.00016.x · Cited by 40
Zaki, P. A., Keith, D. E., Thomas, J. B., Carroll, F. I., & Evans, C. J. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29470-2 · Cited by 40
Cuesta, J., Burokas, A., Mancino, S., Kummer, S., Martín‐García, E., & Maldonado, R. J. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.149 · Cited by 42
Self-citationWalwyn, W. M., John, S., Maga, M., Evans, C. J., & Hales, T. G. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.055913 · Cited by 42
Behavioral changes after maternal separation are reversed by chronic constant light treatment
Dimatelis, J. J., Stein, D. J., & Russell, V. A. (2012) · Brain Research · doi:10.1016/j.brainres.2012.07.013 · Cited by 39
Walwyn, W. M., Maidment, N. T., Sanders, M. J., Evans, C. J., Kieffer, B. L., & Hales, T. G. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014829 · Cited by 39
Self-citationThe Delta Opioid Receptor in Pain Control
Abdallah, K., & Gendron, L. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_32 · Cited by 42
Clozapine-Associated Restless Legs Syndrome
Duggal, H. S., & Mendhekar, D. N. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31802e7587 · Cited by 40
The Application of Adeno-Associated Viral Vector Gene Therapy to the Treatment of Fragile X Syndrome
Hampson, D. R., Hooper, A. W. M., & Niibori, Y. (2019) · Brain Sciences · doi:10.3390/brainsci9020032 · Cited by 40
Bérubé, P., Poulin, J.-F., Laforest, S., & Drolet, G. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.316 · Cited by 40
Mouse Delta Opioid Receptors are Located on Presynaptic Afferents to Hippocampal Pyramidal Cells
Rezaï, X., Faget, L., Bednarek, E., Schwab, Y., Kieffer, B. L., & Massotte, D. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9791-1 · Cited by 37
Self-citationSanchis‐Segura, C., Grisel, J. E., Olive, M. F., Ghozland, S., Koob, G. F., Roberts, A. J., & Cowen, M. S. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000174913.60384.e8 · Cited by 38
Self-citationDelta opioid agonists: a concise update on potential therapeutic applications
Peppin, J. F., & Raffa, R. B. (2015) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12244 · Cited by 42
Opiorphin levels in fluids of burning mouth syndrome patients: a case-control study
Boucher, Y., Braud, A., Dufour, E., Agbo-Godeau, S., Baaroun, V., Descroix, V., Guinnepain, M. T., Ungeheuer, M., Ottone, C., & Rougeot, C. (2016) · Clinical Oral Investigations · doi:10.1007/s00784-016-1991-0 · Cited by 37
Liu, X., & Jernigan, C. S. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.10.007 · Cited by 40
Zádor, F., Kocsis, D., Borsodi, A. D., & Benyhe, S. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2013.12.005 · Cited by 37
The Cholinergic System as a Treatment Target for Opioid Use Disorder
Jensen, K. P., DeVito, E. E., Yip, S. W., Carroll, K. M., & Sofuoglu, M. (2018) · CNS Drugs · doi:10.1007/s40263-018-0572-y · Cited by 38
Halladay, L. R., Iñiguez, S. D., Furqan, F., Previte, M. C., Chisum, A. M., & Crawford, C. A. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.11.011 · Cited by 38
Nielsen, C. K., Simms, J. A., Bito‐Onon, J. J., Li, R., Ananthan, S., & Bartlett, S. E. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00295.x · Cited by 36
Merrer, J. L., Faget, L. C., Matifas, A., & Kieffer, B. L. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2693-1 · Cited by 41
Self-citationCross-talk between metabolism and reproduction: the role of POMC and SF1 neurons
Xu, Y., Faulkner, L. D., & Hill, J. W. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00098 · Cited by 37
In vivo mapping of a GPCR interactome using knockin mice
Degrandmaison, J., Abdallah, K., Blais, V., Génier, S., Lalumière, M.-P., Bergeron, F., Cahill, C. M., Boulter, J., Lavoie, C. L., Parent, J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917906117 · Cited by 42
Artificial microRNA-based neurokinin-1 receptor gene silencing reduces alcohol consumption in mice
Baek, M. N., Jung, K. H., Halder, D., Choi, M., Lee, B.-H., Lee, B.-C., Jung, M. H., Choi, I.-G., Chung, M.-K., Oh, D.-Y., et al. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.03.051 · Cited by 36
Fæste, C. K., Pierre, F., Ivanova, L., Sayyari, A., & Massotte, D. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02470-1 · Cited by 36
Heterozygous loss of epilepsy gene KCNQ2 alters social, repetitive and exploratory behaviors
Kim, E. C., Patel, J., Zhang, J., Soh, H., Rhodes, J. S., Tzingounis, A. V., & Chung, H. J. (2020) · Genes, Brain and Behavior · doi:10.1111/gbb.12599 · Cited by 33
Research and development of κ opioid receptor agonists and δ opioid receptor agonists
Nagase, H., & Saitoh, A. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107427 · Cited by 38
Yoo, J. H., Kitchen, I., & Bailey, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01952.x · Cited by 38
Noble, F., Benturquia, N., Bilkei‐Gorzó, A., Zimmer, A., & Roques, B. P. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0964-z · Cited by 35
Sitbon, P., Elstraete, A. C. V., Hamdi, L., Juarez‐Perez, V., Mazoit, J., Benhamou, D., & Rougeot, C. (2016) · Anesthesiology · doi:10.1097/aln.0000000000001320 · Cited by 35
Usefulness of knockout mice to clarify the role of the opioid system in chronic pain
Maldonado, R. J., Baños, J.-E., & Cabañero, D. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14088 · Cited by 39
Self-citationDisease-Specific Heteromerization of G-Protein-Coupled Receptors That Target Drugs of Abuse
Gomes, I., Fujita, W., Chandrakala, M. V., & Devi, L. A. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-386931-9.00009-x · Cited by 39
Henry, M. S., Bisht, K., Vernoux, N., Gendron, L., Torres-Berrio, A., Drolet, G., & Tremblay, M.-È. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00100 · Cited by 35
μ-Opioid receptor activation prevents acute hepatic inflammation and cell death
Chakass, D. N., Philippe, D., Erdual, E., Dharancy, S., Body–Malapel, M., Dubuquoy, C., Thuru, X., Gay, J., Gavériaux‐Ruff, C., Dubus, P. R., et al. (2007) · Gut · doi:10.1136/gut.2006.105122 · Cited by 35
Self-citationPresynaptic δ Opioid Receptors Regulate Ethanol Actions in Central Amygdala
Kang-Park, M.-H., Kieffer, B. L., Roberts, A. J., Siggins, G. R., & Moore, S. D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.112722 · Cited by 36
Self-citationHahn, Y. K., Paris, J. J., Lichtman, A. H., Hauser, K. F., Sim‐Selley, L. J., Selley, D. E., & Knapp, P. E. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.014 · Cited by 37
Functionality versus dimensionality in psychological taxonomies, and a puzzle of emotional valence
Trofimova, I. N. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0167 · Cited by 37
Polo, S., Díaz, A. F., Gallardo, N., Leánez, S., Balboni, G., & Pol, O. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00283 · Cited by 35
Enhanced humoral response in kappa-opioid receptor knockout mice
Gavériaux‐Ruff, C., Simonin, F., Filliol, D., & Kieffer, B. L. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00419-8 · Cited by 34
Self-citationImpaired water maze learning performance in μ-opioid receptor knockout mice
Jang, C., Lee, S., Yoo, J., Yan, J.-J., Song, D., Loh, H. H., & Ho, I. K. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00291-2 · Cited by 43
Metadata
- Authors
- Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H. W. D., Simonin, F., Befort, K., Gavériaux-Ruff, C., Dierich, A., LeMeur, M., Valverde, O., Maldonado, R., & Kieffer, B. L.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Universitat Pompeu Fabra (ES)
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- Corresponding author
- Kieffer, Brigitte L.
- ORCID
- Venue
- Nature Genetics
- Published
- 2000-06
- Volume
- 25
- Issue
- 2
- Pages
- 195-200
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1505495051
- Cited by
- 672
- References
- 31
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 15 · 2023: 19 · 2022: 18 · 2021: 16 · 2020: 24 · 2019: 29 · 2018: 28 · 2017: 30 · 2016: 41 · 2015: 24 · 2014: 39 · 2013: 35 · 2012: 33
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- delta opioid receptor, mu-opioid receptor, kappa opioid receptor, OprM, anxiety-like behavior, depression-like behavior, emotion regulation, mood disorders, drug addiction, pain
- MeSH terms
- Animals, Anxiety, Binding Sites, Darkness, Depression, Electroshock, Female, Light, Male, Motor Activity, Naloxone, Naltrexone, Narcotic Antagonists, Phenotype, Sex Characteristics, Swimming, Pain Threshold, Gene Deletion, Receptors, Opioid, mu, Receptors, Opioid, delta, Receptors, Opioid, kappa, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.